[96a5a0]: / output / allTrials / identified / NCT03802773_identified.json

Download this file

296 lines (296 with data), 13.2 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
{
"info": {
"nct_id": "NCT03802773",
"official_title": "Cord Blood Transplantation With Myeloablative Conditioning and Post-transplant Cyclophosphamide in Patients With Hematological Malignancies (The COmPACt Study)",
"inclusion_criteria": "* Age: ≥ 18 ≤ 75 years old\n* CB unit transplantation (TNC> 2,0 x10^7/kg and > 4/6 loci HLA matched)\n* Myeloablative conditioning regimen consisting of either Thiotepa/ Busulfan/ Fludarabine or TBI/ Fludarabine\n* GVHD prophylaxis including PT-Cy (30 mg/kg or more on days + 3and +5) CSA and MMF\n* Diagnosis of 1 of the following hematological malignancies: Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome, high risk Acute Lymphoblastic Leukemia (ALL), Bi phenotypic/undifferentiated leukemia, Chronic Myeloid Leukemia resistant to TK inhibitors, Ph-neg Myeloproliferative Neoplasms, resistant/relapsing Non-Hodgkin's lymphoma ineligible for an autologous transplant.\nHealthy volunteers allowed\nMust have minimum age of 18 Years\nMust have maximum age of 75 Years",
"exclusion_criteria": "* Positive serologic markers for human immunodeficiency virus (HIV)\n* Acute hepatitis B virus (HBV) or acute hepatitis C virus (HCV) infection",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* Age: ≥ 18 ≤ 75 years old",
"criterions": [
{
"exact_snippets": "Age: ≥ 18 ≤ 75 years old",
"criterion": "age",
"requirements": [
{
"requirement_type": "N/A",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 18,
"unit": "years"
},
{
"operator": "<=",
"value": 75,
"unit": "years"
}
]
}
}
]
}
]
},
{
"line": "* CB unit transplantation (TNC> 2,0 x10^7/kg and > 4/6 loci HLA matched)",
"criterions": [
{
"exact_snippets": "CB unit transplantation",
"criterion": "CB unit transplantation",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "TNC> 2,0 x10^7/kg",
"criterion": "TNC",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": ">",
"value": 2.0,
"unit": "x10^7/kg"
}
}
]
},
{
"exact_snippets": "> 4/6 loci HLA matched",
"criterion": "HLA loci match",
"requirements": [
{
"requirement_type": "match level",
"expected_value": {
"operator": ">",
"value": 4,
"unit": "loci"
}
}
]
}
]
},
{
"line": "* Myeloablative conditioning regimen consisting of either Thiotepa/ Busulfan/ Fludarabine or TBI/ Fludarabine",
"criterions": [
{
"exact_snippets": "Myeloablative conditioning regimen consisting of either Thiotepa/ Busulfan/ Fludarabine or TBI/ Fludarabine",
"criterion": "myeloablative conditioning regimen",
"requirements": [
{
"requirement_type": "components",
"expected_value": [
"Thiotepa",
"Busulfan",
"Fludarabine",
"TBI"
]
}
]
}
]
},
{
"line": "* GVHD prophylaxis including PT-Cy (30 mg/kg or more on days + 3and +5) CSA and MMF",
"criterions": [
{
"exact_snippets": "GVHD prophylaxis including PT-Cy (30 mg/kg or more on days + 3and +5)",
"criterion": "GVHD prophylaxis",
"requirements": [
{
"requirement_type": "inclusion",
"expected_value": [
"PT-Cy (30 mg/kg or more on days + 3and +5)",
"CSA",
"MMF"
]
}
]
}
]
},
{
"line": "* Diagnosis of 1 of the following hematological malignancies: Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome, high risk Acute Lymphoblastic Leukemia (ALL), Bi phenotypic/undifferentiated leukemia, Chronic Myeloid Leukemia resistant to TK inhibitors, Ph-neg Myeloproliferative Neoplasms, resistant/relapsing Non-Hodgkin's lymphoma ineligible for an autologous transplant.",
"criterions": [
{
"exact_snippets": "Diagnosis of 1 of the following hematological malignancies: Acute Myeloid Leukemia (AML)",
"criterion": "hematological malignancy",
"requirements": [
{
"requirement_type": "type",
"expected_value": "Acute Myeloid Leukemia (AML)"
}
]
},
{
"exact_snippets": "Diagnosis of 1 of the following hematological malignancies: ... Myelodysplastic Syndrome",
"criterion": "hematological malignancy",
"requirements": [
{
"requirement_type": "type",
"expected_value": "Myelodysplastic Syndrome"
}
]
},
{
"exact_snippets": "Diagnosis of 1 of the following hematological malignancies: ... high risk Acute Lymphoblastic Leukemia (ALL)",
"criterion": "hematological malignancy",
"requirements": [
{
"requirement_type": "type",
"expected_value": "high risk Acute Lymphoblastic Leukemia (ALL)"
}
]
},
{
"exact_snippets": "Diagnosis of 1 of the following hematological malignancies: ... Bi phenotypic/undifferentiated leukemia",
"criterion": "hematological malignancy",
"requirements": [
{
"requirement_type": "type",
"expected_value": "Bi phenotypic/undifferentiated leukemia"
}
]
},
{
"exact_snippets": "Diagnosis of 1 of the following hematological malignancies: ... Chronic Myeloid Leukemia resistant to TK inhibitors",
"criterion": "hematological malignancy",
"requirements": [
{
"requirement_type": "type",
"expected_value": "Chronic Myeloid Leukemia resistant to TK inhibitors"
}
]
},
{
"exact_snippets": "Diagnosis of 1 of the following hematological malignancies: ... Ph-neg Myeloproliferative Neoplasms",
"criterion": "hematological malignancy",
"requirements": [
{
"requirement_type": "type",
"expected_value": "Ph-neg Myeloproliferative Neoplasms"
}
]
},
{
"exact_snippets": "Diagnosis of 1 of the following hematological malignancies: ... resistant/relapsing Non-Hodgkin's lymphoma ineligible for an autologous transplant",
"criterion": "hematological malignancy",
"requirements": [
{
"requirement_type": "type",
"expected_value": "resistant/relapsing Non-Hodgkin's lymphoma ineligible for an autologous transplant"
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
},
{
"line": "Must have maximum age of 75 Years",
"criterions": [
{
"exact_snippets": "maximum age of 75 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "maximum",
"expected_value": {
"operator": "<=",
"value": 75,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "* Positive serologic markers for human immunodeficiency virus (HIV)",
"criterions": [
{
"exact_snippets": "Positive serologic markers for human immunodeficiency virus (HIV)",
"criterion": "HIV serologic markers",
"requirements": [
{
"requirement_type": "presence",
"expected_value": "positive"
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [
{
"line": "* Acute hepatitis B virus (HBV) or acute hepatitis C virus (HCV) infection",
"criterions": [
{
"exact_snippets": "Acute hepatitis B virus (HBV) infection",
"criterion": "acute hepatitis B virus infection",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "Acute hepatitis C virus (HCV) infection",
"criterion": "acute hepatitis C virus infection",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
}
],
"failed_miscellaneous": []
}